Endocarditis infection commonly related to health care factors, increasingly due to staphJune 21, 2005An international study reveals that infective endocarditis, infection and inflammation involving the heart valves is commonly associated with health care factors and is increasingly due to staphylococcal infection, according to a study in the June 22/29 issue of JAMA. For decades, infective endocarditis (IE) caused by Staphylococcus aureus has been viewed primarily as a community-acquired disease, especially associated with injection drug use, according to background information in the article. Because no large, prospectively collected, and geographically diverse cohort of patients with IE existed before now, the global significance and impact of regional variations on the characteristics, treatment, and outcome of S aureus IE has not been known. Vance G. Fowler, Jr., M.D., M.H.S., of Duke University Medical Center, Durham, N.C., and colleagues conducted a study to document the characteristics of IE caused by S aureus, including IE associated with health care contact and IE due to methicillin-resistant S aureus (MRSA), in different parts of the world; and assessed regional differences and the effect of these differences on clinical outcomes among patients with S aureus IE. The study included 1,779 patients with IE from 39 medical centers in 16 countries. The patients were enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study from June 2000 to December 2003.
The researchers found that S aureus was the most common pathogen among the 1779 cases (558 patients, 31.4 percent). Health care-associated infection was the most common form of S aureus IE (218 patients, 39.1 percent), accounting for 25.9 percent (Australia/New Zealand) to 54.2 percent (Brazil) of cases. Most patients with health care-associated S aureus IE (131 patients, 60.1 percent) acquired the infection outside of the hospital. MRSA IE was more common in the United States (37.2 percent) and Brazil (37.5 percent) than in Europe/Middle East (23.7 percent) and Australia/New Zealand (15.5 percent). Patients in the United States were most likely to be hemodialysis dependent, to have diabetes, to have a presumed intravascular device source, to receive vancomycin, to be infected with MRSA, and to have persistent bacteremia. "The finding of S aureus as the leading cause of IE differs from previous reports and may be due in part to increasing rates of staphylococcal bacteremia related to health care contact in industrialized nations," the authors write. "S aureus is now the most common cause of IE in many areas of the developed world. Patients with IE due to S aureus exhibit distinct characteristics compared with patients with IE due to other pathogens. Health care�associated IE is emerging as the most common form of S aureus IE and has distinct features compared with more familiar forms of S aureus IE, such as community-acquired injection drug use-associated infection. MRSA is now encountered internationally as a relatively common cause of IE and is associated with persistent bacteremia. Future investigations are required to identify better treatment and prevention strategies for this serious and common consequence of medical progress," the authors conclude. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Endocarditis Current Events and Endocarditis News Articles Scientists discover 21st century plague Bacteria that can cause serious heart disease in humans are being spread by rat fleas, sparking concern that the infections could become a bigger problem in humans. Infectious heart disease death rates rising again say scientists Infectious heart disease is still a major killer in spite of improvements in health care, but the way the disease develops has changed so much since its discovery that nineteenth century doctors would not recognize it. New step forward in search for solution to infection puzzle Scientists at the University of York have helped to reveal more about the way bacteria can attach to human tissues. Turning on cell-cell communication wipes out staph biofilms University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems. Although the discovery is not ready for clinical application, the findings offer insight into a dispersal mechanism for staph biofilms and might help identify therapeutic targets. Fewer heart patients need antibiotics before dental procedures Based on a review of new and existing scientific evidence, most dental patients with heart disease do not need antibiotics before dental procedures to prevent infective endocarditis (IE), a rare, but life-threatening heart infection. Most patients don't need antibiotics before dental procedures Taking a precautionary antibiotic before a trip to the dentist isn¡¦t necessary for most people, and in fact, might create more harm than good, according to updated recommendations from the American Heart Association. Scientists decode genome of oral pathogen Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream. Staph vaccine shows promise in mouse study By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. New Treatment - First in Years - Demonstrated For Dangerous Staph Infections Duke University Medical Center researchers have demonstrated in an international clinical trial the effectiveness and safety of a new drug for treating bloodstream and heart infections caused by Staphylococcus aureus bacteria, a major cause of sickness and death worldwide. New ACC/AHA guidelines released for valvular heart disease An updated set of guidelines jointly released by the American College of Cardiology (ACC) and the American Heart Association (AHA) draws together the latest information on the diagnosis and treatment of patients with valvular heart disease. More Endocarditis Current Events and Endocarditis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||